With top-line pivotal data with gene therapy RGX-202 for Duchenne muscular dystrophy (DMD) due in the next quarter, Regenxbio Inc. rolled out positive interim data from the phase I/II Affinity trial at the Muscular Dystrophy Association Clinical and Scientific Conference (MDA) in Orlando, Fla., where Bridgebio Pharma Inc., Capricor Therapeutics Inc., and Solid Biosciences Inc. also had clinical findings to talk about. Read More
Stryker Corp. is scrambling to recover from a cyberattack that’s disrupting its global network and being claimed by pro-Iranian hackers. “At this time, there is no indication of malware or ransomware, and we believe the situation is contained to our internal Microsoft environment only,” the Kalamazoo, Mich.-based med-tech company said March 12. Read More
U.K. biopharma is working with the country’s space agency and Civil Aviation Authority (CAA) to plot a route for manufacturing biologic drugs in low earth orbit. Read More
The BioWorld Neurological Diseases Index (BNDI) finished 2025 up 6.33%, continuing the gains seen through November (closing up 2.64%), after reaching a low in July when it was down 22.48%. By comparison, the Nasdaq Biotechnology Index (NBI) ended the year up 32.4%, while the Dow Jones Industrial Average (DJIA) rose 12.97%. In the first two months of 2026, the BNDI slipped 1.24%, compared with gains of 5.85% for the NBI and 1.9% for the DJIA. Read More
Scientists at Duke University have uncovered how macrophages help maintain intraocular pressure and have found that a specific type, resident macrophages, is essential for proper drainage of intraocular fluid. When these cells are removed, drainage becomes impaired and intraocular pressure rises, contributing to the development of glaucoma. Read More
New hires and promotions in the biopharma and med-tech industries, including: Aim Medical Robotics, Aurion, Bionexus, Certus, Cognito, Commit, Curanex, Fidelion, Mainz, Skyhawk. Read More
Biopharma and med-tech companies raising money in public or private financings, including: Bioxcel, Catheter Precision, Crispr, Dianthus, Emboline, Nurexone, Sandoz, Vima, Vitestro, Xenon. Read More
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: 60 Degrees, Ahngook, Curatis, Eli Lilly, Esteve, Evotec, George Medicines, Neupharma, Tersera. Read More
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Arthex, Cairn, Cellavision, Memed, Minimed, Parabilis, Qiagen, Quoin, Tolerogenixx. Read More
